Compare VHI & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VHI | PACB |
|---|---|---|
| Founded | 1932 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 393.4M | 459.0M |
| IPO Year | 1994 | 2010 |
| Metric | VHI | PACB |
|---|---|---|
| Price | $13.57 | $1.32 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $12.00 | $2.10 |
| AVG Volume (30 Days) | 15.5K | ★ 4.8M |
| Earning Date | 03-10-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.36% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,077,000,000.00 | $93,468,000.00 |
| Revenue This Year | $33.32 | $11.22 |
| Revenue Next Year | N/A | $12.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $11.44 | $0.85 |
| 52 Week High | $20.00 | $2.73 |
| Indicator | VHI | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 42.91 | 37.13 |
| Support Level | $12.02 | $1.19 |
| Resistance Level | $13.32 | $1.37 |
| Average True Range (ATR) | 0.72 | 0.09 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 29.19 | 18.75 |
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.